The European Commission (EC) has approved Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin) plus the ...

Takeda (NYSE:TAK) (4502.T) said on Monday that the European Commission approved Pfizer (NYSE:PFE) and the company's ...

Applications are now open for the Takeda Innovators in Science Award with Nature recognizing the groundbreaking research of ...

"I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms ...

The European Commission (EC) has approved Adcetris (brentuximab vedotin) in combination with etoposide, cyclophosphamide, ...

Takeda Pharmaceutical Company Limited (NYSE: TAK )’s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized ...

Step into the world of high-end collectible figures with the MOSHOW TOYS Progenitor Effect Takeda Shingen METAL FRAME, a ...

The drug has been approved in combination with the chemotherapy regimen etoposide, cyclophosphamide, doxorubicin, dacarbazine ...

Osaka: Takeda has received approval from the European Commission (EC) for ADCETRIS (brentuximab vedotin) in combination with ...

US drugmaker Protagonist Therapeutics (Nasdaq: PTGX) and Japan’s Takeda Pharma (TYO:4502) announced detailed results from the ...

Japanese rookie Rio Takeda finished tied for second at the U.S. Women's Open on Sunday as overnight leader Maja Stark of Sw ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...